Drug Target Review

The scale divide: competing strategies in AI drug discovery

Two approaches to AI in preclinical drug discovery are diverging, from multi-thousand GPU systems to models with only a ...

AI could move from decoding biology to mapping civilization, turning chaotic history into patterns that may explain how societies rise and fall

AI is moving beyond biology to decode human history, searching for hidden patterns that explain how societies rise and ...

Alphabet’s Isomorphic Labs reportedly raising $2B+ for its medical research AI

In 2024, DeepMind and Isomorphic Labs released a significantly improved successor to the model. AlphaFold 3 delivers a more ...
Drug Target Review

From leaderboards to lab notebooks: AI designs reach preclinical testing

For years, AI drug discovery has been judged on benchmark performance. Now, a set of studies shows what happens when those ...

How AI Can Beat Cancer

We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.
The Next Web

The company that built TikTok’s algorithm is now designing drugs for diseases pharma called undruggable

ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.

[Exclusive] AI Drug Development Breakthrough: Achieving Both Efficacy and Productivity

Domestic researchers have made significant progress toward developing artificial intelligence (AI)-based antibody drugs that ...
MIT Technology Review

Artificial scientists

AI has already proved itself a valuable scientific tool. Could it take on a more central role in the research process?